Does whey raise IGF-1 in healthy young adults?

Much less. The trials showing clear increases were in older adults with low baseline protein intake, where the deficit was the limiting factor.

Is whey better than other proteins for this?

Its leucine content and rapid digestion give it an advantage per serving, but total daily protein intake matters more than the source.

Should I be worried about raising IGF-1?

At the intakes studied, IGF-1 returns toward a normal range rather than exceeding it. The concern applies to pharmacological growth hormone use, not dietary protein.

Outcome

Moderate Evidence

Whey Protein for Insulin-Like Growth Factor

Adequate protein, including whey, supports IGF-1 in older adults where intake is low.

Overview

Insulin-like growth factor 1 is the principal anabolic mediator downstream of growth hormone, and it is sensitive to protein and energy intake. Whey protein raises circulating IGF-1 modestly in people whose protein intake was previously inadequate, and that rise usually travels alongside gains in lean mass and strength.

The clearest randomised data come from sarcopenic older adults, where whey combined with vitamin D and resistance activity increased fat-free mass, strength and IGF-1 concentrations against placebo. Similar multi-nutrient trials preserved muscle mass and improved anabolic markers. Two things follow. First, the effect is largely a correction of insufficient protein rather than a pharmacological boost. Second, IGF-1 is a marker in these trials, not the goal: the reason to care is the muscle and function outcome it accompanies.

Verdict

Likely effective

Randomised trials in sarcopenic older adults show whey-based supplementation raises IGF-1 alongside fat-free mass and strength. Effects are largest where baseline protein intake is low.

How It Works

Hepatic IGF-1 production requires both adequate amino acid supply and sufficient energy intake; in undernutrition the liver becomes resistant to growth hormone and IGF-1 falls. Restoring protein intake removes that constraint, which is the main reason supplementation moves the number.

Whey is well suited to this because it is rapidly digested and unusually high in leucine, which activates mTORC1 in skeletal muscle and drives a sharp postprandial rise in muscle protein synthesis. Local muscle IGF-1 expression also increases with loading, which is why resistance exercise and protein together outperform either alone. The ceiling is real. In someone already eating 1.2 g of protein per kilogram with adequate energy, additional whey has little room to raise IGF-1 further.

Primary driver: Amino acid and energy availability for hepatic IGF-1 synthesis
Key amino acid: Leucine, activating mTORC1
Required co-factor: Resistance loading for local muscle IGF-1
Responder profile: Low baseline protein intake, older adults, sarcopenia
Ceiling effect: Little added benefit above roughly 1.2 g/kg/day protein

Dosing & Protocol

The trials used roughly 20 to 40 g of whey daily, frequently split into two servings and combined with vitamin D. Total daily protein intake matters more than the supplement dose itself, so the practical target is to reach 1.2 to 1.6 g per kilogram per day, using whey to fill the gap.

Context	Dose	Form	Timing
Sarcopenia trial dose	20-40 g daily	Whey concentrate or isolate, often with vitamin D	Split into two servings
Per-serving leucine target	2.5-3 g leucine (~25 g whey)	Whey isolate or concentrate	With or after training
Total protein target	1.2-1.6 g/kg/day	Food plus supplement	Spread across 3-4 meals
Lactose intolerance	20-30 g daily	Whey isolate or hydrolysate	Any meal

1
Count your current protein first· Week 0
Track intake for three days. If you are already above 1.2 g/kg, extra whey is unlikely to move IGF-1.
2
Add 20-40 g whey daily· Daily
Split across two servings to hit the leucine threshold twice rather than once.
3
Add resistance training· 2-3 sessions weekly
Every positive trial paired supplementation with physical activity. Protein without loading changes far less.
4
Check vitamin D status· Baseline
The trials used whey with vitamin D. Correcting a deficiency is part of the tested intervention.
5
Reassess at 12 weeks· Week 12
Strength and lean mass are the meaningful readouts; IGF-1 is the mechanism marker.

Higher IGF-1 is not automatically better

IGF-1 is valuable here as a signal that anabolic capacity has been restored. Chasing the highest possible number is not a health goal, and epidemiology on very high IGF-1 is not uniformly reassuring.

Evidence

Both linked trials are randomised, both are in sarcopenic older adults and both used whey within a multi-nutrient formulation alongside activity. That design choice is the key limitation: it makes the whey-specific contribution to the IGF-1 change hard to isolate.

Randomised trials linked to this pairing.

Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life in sarcopenic elderly

Score: 8/10

2016

rct

n=130

Rondanelli M, Klersy C

Whey protein, amino acids and vitamin D increased fat-free mass, strength and IGF-1 in sarcopenic elderly

View source

A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in sarcopenic older adults: A double-blind randomized controlled trial

Score: 7/10

2019

rct

Bo Y, Liu C

A high whey protein, vitamin D and E supplement preserved muscle mass and strength in sarcopenic older adults

View source

Best available evidence: Randomised controlled trials in sarcopenic older adults (n=130 and similar)
Typical effect: Increased IGF-1 with concurrent gains in fat-free mass and strength
Studied dose: 20-40 g whey daily, with vitamin D and physical activity
Time to effect: 12 weeks
Main limitation: Multi-nutrient designs prevent isolating the whey-specific effect

Safety

Whey is among the best-tolerated supplements available. Digestive complaints are the usual issue and mostly reflect lactose in concentrate rather than the protein itself; isolate resolves this for most people. There is no evidence of kidney harm from higher protein intake in people with normal renal function.

What to watch

Bloating or gas from lactose in whey concentrate

Not suitable with cows milk protein allergy

Caution in established chronic kidney disease

Displaces whole foods if overused

Some products carry heavy metal or additive concerns

Interactions & Conflicts

Whey has few pharmacological interactions, but protein-rich meals can interfere with the absorption of several drugs, and that is the practical issue for anyone timing supplements around medication.

Interacts with	Severity	Mechanism	Action
Levodopa	moderate	Large neutral amino acids compete with levodopa for transport	Separate whey and levodopa by at least one hour
Levothyroxine	low	Food and protein reduce absorption	Take levothyroxine fasted, whey later
Tetracycline and quinolone antibiotics	moderate	Calcium in dairy protein binds the drug	Separate by two hours
Chronic kidney disease management	moderate	Protein load raises filtration demand	Only under renal dietetic supervision

References

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.